Terms: = Uterine cancer AND FGFR1OP, FOP, 11116, ENSG00000213066
11 results:
1. LGR6 activates the Wnt/β-catenin signaling pathway and forms a β-catenin/TCF7L2/LGR6 feedback loop in LGR6
Feng Q; Li S; Ma HM; Yang WT; Zheng PS
Oncogene; 2021 Oct; 40(42):6103-6114. PubMed ID: 34489551
[TBL] [Abstract] [Full Text] [Related]
2. HOXA5 inhibits the proliferation and neoplasia of cervical cancer cells via downregulating the activity of the Wnt/β-catenin pathway and transactivating TP53.
Ma HM; Cui N; Zheng PS
Cell Death Dis; 2020 Jun; 11(6):420. PubMed ID: 32499530
[TBL] [Abstract] [Full Text] [Related]
3. SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1.
Chen M; Li L; Zheng PS
Cancer Sci; 2019 Sep; 110(9):2794-2805. PubMed ID: 31336010
[TBL] [Abstract] [Full Text] [Related]
4. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
Hsu W; Liu L; Chen X; Zhang Y; Zhu W
Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
[TBL] [Abstract] [Full Text] [Related]
5. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
Li L; Yang WT; Zheng PS; Liu XF
Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
[TBL] [Abstract] [Full Text] [Related]
6. DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt/β-catenin pathway via GSK3β.
Liu XF; Li XY; Zheng PS; Yang WT
Cell Death Dis; 2018 Mar; 9(3):339. PubMed ID: 29497051
[TBL] [Abstract] [Full Text] [Related]
7. miR-15a-5p suppresses endometrial cancer cell growth via Wnt/β-catenin signaling pathway by inhibiting WNT3A.
Wang ZM; Wan XH; Sang GY; Zhao JD; Zhu QY; Wang DM
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4810-4818. PubMed ID: 29164582
[TBL] [Abstract] [Full Text] [Related]
8. Fear of cancer recurrence and its predictors among cervical cancer survivors.
Hanprasertpong J; Geater A; Jiamset I; Padungkul L; Hirunkajonpan P; Songhong N
J Gynecol Oncol; 2017 Nov; 28(6):e72. PubMed ID: 28758378
[TBL] [Abstract] [Full Text] [Related]
9. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract] [Full Text] [Related]
10. Elevated glucose levels impair the WNT/β-catenin pathway via the activation of the hexosamine biosynthesis pathway in endometrial cancer.
Zhou F; Huo J; Liu Y; Liu H; Liu G; Chen Y; Chen B
J Steroid Biochem Mol Biol; 2016 May; 159():19-25. PubMed ID: 26923859
[TBL] [Abstract] [Full Text] [Related]
11. Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
Am J Pathol; 2004 May; 164(5):1739-49. PubMed ID: 15111320
[TBL] [Abstract] [Full Text] [Related]